| 000 | 01907 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518071509.0 | ||
| 264 | 0 | _c20200714 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a1433-7339 | ||
| 024 | 7 |
_a10.1007/s00520-019-05168-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRogiers, A | |
| 245 | 0 | 0 |
_aHealth-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study. _h[electronic resource] |
| 260 |
_bSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _cJul 2020 |
||
| 300 |
_a3267-3278 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
| 650 | 0 | 4 |
_aAnxiety _xetiology |
| 650 | 0 | 4 |
_aCancer Survivors _xpsychology |
| 650 | 0 | 4 |
_aDepression _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aNeurocognitive Disorders _xetiology |
| 650 | 0 | 4 | _aPatient Reported Outcome Measures |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aStress, Psychological _xetiology |
| 700 | 1 | _aLeys, C | |
| 700 | 1 | _aDe Cremer, J | |
| 700 | 1 | _aAwada, G | |
| 700 | 1 | _aSchembri, A | |
| 700 | 1 | _aTheuns, P | |
| 700 | 1 | _aDe Ridder, M | |
| 700 | 1 | _aNeyns, B | |
| 773 | 0 |
_tSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _gvol. 28 _gno. 7 _gp. 3267-3278 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00520-019-05168-3 _zAvailable from publisher's website |
| 999 |
_c30331055 _d30331055 |
||